Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

TC Chou - Pharmacological reviews, 2006 - ASPET
The median-effect equation derived from the mass-action law principle at equilibrium-steady
state via mathematical induction and deduction for different reaction sequences and …

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

M Baccarani, G Saglio, J Goldman, A Hochhaus… - Blood, 2006 - ashpublications.org
The introduction of imatinib mesylate (IM) has revolutionized the treatment of chronic
myeloid leukemia (CML). Although experience is too limited to permit evidence-based …

A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi

TF Dos Reis, PA De Castro, RW Bastos… - Nature …, 2023 - nature.com
Fungal infections cause more than 1.5 million deaths a year. Due to emerging antifungal
drug resistance, novel strategies are urgently needed to combat life-threatening fungal …

RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis

HK Bid, RD Roberts, PK Manchanda… - Molecular cancer …, 2013 - AACR
Angiogenesis and metastasis are well recognized as processes fundamental to the
development of malignancy. Both processes involve the coordination of multiple cellular and …

The survival kinases Akt and Pim as potential pharmacological targets

R Amaravadi, CB Thompson - The Journal of clinical …, 2005 - Am Soc Clin Investig
The Akt and Pim kinases are cytoplasmic serine/threonine kinases that control programmed
cell death by phosphorylating substrates that regulate both apoptosis and cellular …

Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies

J Rosenbloom, SV Castro… - Annals of internal medicine, 2010 - acpjournals.org
Abnormal and exaggerated deposition of extracellular matrix is the hallmark of many fibrotic
diseases, including systemic sclerosis and pulmonary, liver, and kidney fibrosis. The …

Pharmacological targeting of endoplasmic reticulum stress signaling in cancer

AH Schönthal - Biochemical pharmacology, 2013 - Elsevier
The endoplasmic reticulum (ER) stress response constitutes a cellular process that can be
triggered by a great variety of conditions that cause imbalances in intracellular homeostasis …

Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development

A Burchert, Y Wang, D Cai, N Von Bubnoff, P Paschka… - Leukemia, 2005 - nature.com
BCR/ABL-kinase mutations frequently mediate clinical resistance to the selective tyrosine
kinase inhibitor Imatinib mesylate (IM, Gleevec®). However, mechanisms that promote …

The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia

R Polak, M Buitenhuis - Blood, The Journal of the American …, 2012 - ashpublications.org
An important mediator of cytokine signaling implicated in regulation of hematopoiesis is the
PI3K/protein kinase B (PKB/c-Akt) signaling module. Constitutive activation of this signaling …

Rho GTPases: promising cellular targets for novel anticancer drugs

G Fritz, B Kaina - Current cancer drug targets, 2006 - ingentaconnect.com
Ras-homologous (Rho) GTPases play a pivotal role in the regulation of numerous cellular
functions associated with malignant transformation and metastasis. Rho GTPases are …